IL160769A0 - Heterocyclic compounds and pharmaceutical compositions containing the same - Google Patents

Heterocyclic compounds and pharmaceutical compositions containing the same

Info

Publication number
IL160769A0
IL160769A0 IL16076902A IL16076902A IL160769A0 IL 160769 A0 IL160769 A0 IL 160769A0 IL 16076902 A IL16076902 A IL 16076902A IL 16076902 A IL16076902 A IL 16076902A IL 160769 A0 IL160769 A0 IL 160769A0
Authority
IL
Israel
Prior art keywords
same
pharmaceutical compositions
compositions containing
heterocyclic compounds
compounds
Prior art date
Application number
IL16076902A
Other languages
English (en)
Original Assignee
Morphochem Ag Komb Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morphochem Ag Komb Chemie filed Critical Morphochem Ag Komb Chemie
Publication of IL160769A0 publication Critical patent/IL160769A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16076902A 2001-10-04 2002-10-04 Heterocyclic compounds and pharmaceutical compositions containing the same IL160769A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32716201P 2001-10-04 2001-10-04
PCT/EP2002/011163 WO2003032962A2 (en) 2001-10-04 2002-10-04 Dual action antibiotics

Publications (1)

Publication Number Publication Date
IL160769A0 true IL160769A0 (en) 2004-08-31

Family

ID=23275422

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16076902A IL160769A0 (en) 2001-10-04 2002-10-04 Heterocyclic compounds and pharmaceutical compositions containing the same
IL160769A IL160769A (en) 2001-10-04 2004-03-07 Heterocyclic compounds and pharmaceutical compositions containing the same

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL160769A IL160769A (en) 2001-10-04 2004-03-07 Heterocyclic compounds and pharmaceutical compositions containing the same

Country Status (21)

Country Link
US (2) US7820823B2 (ja)
EP (1) EP1432705B1 (ja)
JP (2) JP4398245B2 (ja)
KR (2) KR100927864B1 (ja)
CN (2) CN1630655A (ja)
AT (1) ATE369363T1 (ja)
AU (1) AU2002361948B2 (ja)
BR (1) BRPI0213063B8 (ja)
CA (1) CA2460572C (ja)
CY (1) CY1107503T1 (ja)
DE (1) DE60221684T2 (ja)
DK (1) DK1432705T3 (ja)
ES (1) ES2287354T3 (ja)
HK (1) HK1128469A1 (ja)
HU (1) HU229935B1 (ja)
IL (2) IL160769A0 (ja)
NZ (1) NZ531879A (ja)
PL (1) PL210850B1 (ja)
PT (1) PT1432705E (ja)
WO (2) WO2003031443A1 (ja)
ZA (1) ZA200401909B (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396847B2 (en) 2001-09-11 2008-07-08 Astrazeneca Ab Oxazolidinone and/or isoxazoline as antibacterial agents
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
NZ543757A (en) * 2003-04-30 2009-02-28 Morphochem Ag Komb Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
WO2004101552A1 (en) * 2003-05-14 2004-11-25 Orchid Chemicals & Pharmaceuticals Ltd Oxazolidinone derivatives as antibacterial agents
DE10340485B4 (de) * 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
EP1557416A1 (en) * 2004-01-23 2005-07-27 Morphochem Aktiengesellschaft Für Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
CN106957316A (zh) 2003-12-18 2017-07-18 莫弗凯姆联合化学股份公司 噁唑烷酮‑喹诺酮杂化物抗生素
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
WO2005111030A1 (en) * 2004-05-12 2005-11-24 Warner-Lambert Company Llc Quinolone antibacterial agents
US20060105941A1 (en) * 2004-11-12 2006-05-18 Allergan, Inc. Mixed antibiotic codrugs
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
KR20080086921A (ko) 2005-12-30 2008-09-26 노파르티스 아게 레닌 억제제로서의 ３,５-치환된 피페리딘 화합물
MX2008012488A (es) * 2006-03-28 2008-10-10 Procter & Gamble Un proceso de acoplamiento para preparar intermedios de quinolona.
EP2009012B1 (en) * 2006-03-31 2014-06-25 Research Foundation Itsuu Laboratory Novel compound having heterocyclic ring
US8124623B2 (en) 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
SG182223A1 (en) 2007-06-25 2012-07-30 Novartis Ag N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
EP2212291B1 (en) * 2007-10-24 2014-06-04 Merck Sharp & Dohme Corp. Heterocycle phenyl amide t-type calcium channel antagonists
AR071762A1 (es) * 2008-05-09 2010-07-14 Actelion Pharmaceuticals Ltd Derivados 5-hidroximetil-oxazolidin-2-ona para el tratamiento de enfermedades intestinales bacteriales
WO2010081851A1 (en) 2009-01-14 2010-07-22 Genoscience Pharma Piperidin-4-ylpiperazine compounds for the treatment of hcv infection
KR20150126032A (ko) 2013-03-08 2015-11-10 알러간, 인코포레이티드 스테로이드 약물과 직접 결합된 항생제 컨쥬게이트
BR112015021388A2 (pt) 2013-03-08 2017-07-18 Allergan Inc conjugados esteroides de ciclosporina a
CN103145615B (zh) * 2013-03-20 2015-07-29 浙江医药股份有限公司 一种奈诺沙星螯合物的后处理方法
NZ713945A (en) 2013-05-28 2020-05-29 Morphochem Aktiengesellschaft Fuer Komb Chemie Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or prophylaxis of bacterial diseases
AU2014273471B2 (en) * 2013-05-28 2019-10-03 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Combination therapy comprising oxazolidinone-quinolones for use in treating bacterial infections
CN103421008B (zh) * 2013-09-07 2015-05-27 吉首大学 一类多靶点呋喃酮-喹啉酮型化合物及其制法和用途
CN107286182A (zh) * 2016-04-12 2017-10-24 李靖 新型噁唑烷酮‑氟喹诺酮衍生物及用途
CN107648181B (zh) * 2016-07-25 2021-05-04 广东赛法洛药业有限公司 一种利他唑酮磷脂复合物及其制备方法和应用
US10087171B2 (en) 2016-12-19 2018-10-02 Actelion Pharmaceuticals Ltd Crystalline forms of cadazolid
CN109942546B (zh) * 2019-04-16 2022-04-08 西南大学 喹诺酮嘧啶类化合物及其制备方法和应用
CN118201916A (zh) * 2021-10-26 2024-06-14 豪夫迈·罗氏有限公司 用于治疗细菌感染的哌嗪基磺酰基芳基化合物

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4840956A (en) * 1986-02-18 1989-06-20 Warner-Lambert Company Novel disubstituted-7-pyrrolidinoquinoline antibacterial agents
NZ222047A (en) 1986-10-08 1991-01-29 Bristol Myers Co Quinoline - or naphthyridine - carboxylic acid anti-bacterial agents
JPH0269478A (ja) 1988-09-05 1990-03-08 Sagami Chem Res Center キノロンカルボン酸誘導体
US5491139A (en) 1988-10-24 1996-02-13 The Procter & Gamble Company Antimicrobial quinolonyl lactams
US5153203A (en) 1989-03-30 1992-10-06 Wakunaga Seiyaku Kabushiki Kaisha Quinolone derivatives and salts thereof, preparation processes thereof, and antibacterial agents containing the same
AU667198B2 (en) * 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
US5221676A (en) * 1992-02-06 1993-06-22 Warner-Lambert Company 7-substituted quinolones and naphthyridones as antibacterial agents
KR100343331B1 (ko) * 1995-09-22 2002-07-15 기스케 와구나가, 구사이 요시히로 신규 피리돈카르복실산 유도체 또는 그 염 및 이 물질을유효성분으로 하는 항균제
DE19601265A1 (de) 1996-01-16 1997-07-17 Bayer Ag 2-Oxo- und 2-Thio-1,2-dihydrochinolinyl-oxazolidinone
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
DE19633480A1 (de) * 1996-08-20 1998-02-26 Bayer Ag Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
GB9725244D0 (en) * 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
AU764184B2 (en) * 1998-01-23 2003-08-14 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
TW572757B (en) 1998-08-24 2004-01-21 Bristol Myers Squibb Co Novel isoxazolinone antibacterial agents
KR100324621B1 (ko) 1999-04-27 2002-02-27 박호군 퀴놀론이 치환된 옥사졸리디논 유도체 및 그의 제조 방법과 항균제로서의 용도
IL147503A0 (en) 1999-07-28 2002-08-14 Upjohn Co Oxazolidinone compounds and methods of preparation and use thereof
US6518285B2 (en) 1999-12-21 2003-02-11 Ortho Mcneil Pharmaceutical, Inc. Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
JP2004518677A (ja) 2000-12-21 2004-06-24 ファルマシア・アンド・アップジョン・カンパニー 抗菌性キノロン誘導体および細菌感染を治療するためのその使用
ES2186550B2 (es) 2001-06-27 2003-11-16 Vita Lab Nuevos derivados de oxazolidinonas como antibacterianos.
WO2003031441A1 (en) 2001-10-04 2003-04-17 Morphochen Aktiengesellschaft Für Kombinatorische Chemie Multiple action compounds
WO2003031443A1 (en) 2001-10-04 2003-04-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety
US20040132764A1 (en) 2002-10-23 2004-07-08 Morphochem Aktiengesellschaft Fuer Kombinatorische Chemie Antibiotics for the treatment of infections in acidic environments
EP1594852A1 (en) 2003-02-07 2005-11-16 Ranbaxy Laboratories, Ltd. Oxazolidinone derivatives as antimicrobials
NZ543757A (en) 2003-04-30 2009-02-28 Morphochem Ag Komb Chemie Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
DE10340485B4 (de) 2003-09-03 2015-05-13 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von Oxazolidinon-Chinolon Hybriden
US8158797B2 (en) 2003-12-18 2012-04-17 Morphochem Aktiengesellschaft Fur Kombinatorische Chemie Oxazolidinone-quinolone hybrid antibiotics
CN106957316A (zh) 2003-12-18 2017-07-18 莫弗凯姆联合化学股份公司 噁唑烷酮‑喹诺酮杂化物抗生素
AR054608A1 (es) 2005-08-08 2007-06-27 Actelion Pharmaceuticals Ltd Derivados de oxazolidinona enlazados a quinolonas como antibacterianos
KR200430712Y1 (ko) 2006-08-30 2006-11-13 명 식 신 천장등
WO2008056335A1 (en) 2006-11-10 2008-05-15 Actelion Pharmaceuticals Ltd 5-hydroxymethyl-oxazolidin-2-one derivatives
US8124623B2 (en) * 2006-11-10 2012-02-28 Actelion Pharmaceuticals Ltd. 5-hydroxymethyl-oxazolidin-2-one-derivatives and their uses as antibacterials
CL2007003332A1 (es) 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
AR071762A1 (es) 2008-05-09 2010-07-14 Actelion Pharmaceuticals Ltd Derivados 5-hidroximetil-oxazolidin-2-ona para el tratamiento de enfermedades intestinales bacteriales

Also Published As

Publication number Publication date
PL367517A1 (en) 2005-02-21
US7820823B2 (en) 2010-10-26
EP1432705A2 (en) 2004-06-30
DE60221684D1 (de) 2007-09-20
WO2003031443A1 (en) 2003-04-17
KR100927864B1 (ko) 2009-11-23
CN1630655A (zh) 2005-06-22
PT1432705E (pt) 2007-08-27
EP1432705B1 (en) 2007-08-08
AU2002361948B2 (en) 2007-03-29
CN101381365A (zh) 2009-03-11
ES2287354T3 (es) 2007-12-16
BRPI0213063B1 (pt) 2018-02-14
ZA200401909B (en) 2005-05-25
CN101381365B (zh) 2011-07-06
CA2460572A1 (en) 2003-04-24
PL210850B1 (pl) 2012-03-30
CY1107503T1 (el) 2013-03-13
DK1432705T3 (da) 2007-09-17
HK1128469A1 (en) 2009-10-30
JP2010006814A (ja) 2010-01-14
HUP0402126A2 (hu) 2005-02-28
IL160769A (en) 2009-12-24
BRPI0213063B8 (pt) 2021-05-25
WO2003032962A2 (en) 2003-04-24
NZ531879A (en) 2005-10-28
KR100987696B1 (ko) 2010-10-13
DE60221684T2 (de) 2008-04-30
BR0213063A (pt) 2004-09-28
US8329908B2 (en) 2012-12-11
ATE369363T1 (de) 2007-08-15
KR20090100426A (ko) 2009-09-23
WO2003032962A3 (en) 2003-07-17
HUP0402126A3 (en) 2012-10-29
CA2460572C (en) 2011-11-08
JP4398245B2 (ja) 2010-01-13
JP2005529061A (ja) 2005-09-29
US20050096343A1 (en) 2005-05-05
KR20040055781A (ko) 2004-06-26
US20110059946A1 (en) 2011-03-10
HU229935B1 (en) 2015-01-28

Similar Documents

Publication Publication Date Title
IL160769A0 (en) Heterocyclic compounds and pharmaceutical compositions containing the same
IL175409A0 (en) Oxazolidinone-quinolone hybrid derivatives and pharmaceutical compositions containing the same
TW200510368A (en) Pharmaceutical compositions and combinations of novel non-imidazole compounds
HK1068136A1 (en) Muscarinic antagonists
MY126917A (en) Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
PL312196A1 (en) Heterocyclic phenyl compounds as inhibitors of cyclooxygenase-2
IL143545A0 (en) Thrombin inhibitors
PL358281A1 (en) Novel compounds
GB0127903D0 (en) Improvements relating to organic compounds
DE60112330D1 (en) Pyrazolopyridinderivate
MXPA04006266A (es) Pirimidotriazinas como inhibidores de fosfatasa.
AP2001002191A0 (en) 3,3- Biarylpiperine and 2,2-biarylmorpholine derivatives.
MY128241A (en) Substituted tetracyclic pyrroloquinolone derivatives useful as phosphodiesterase inhibitors
UA85502C2 (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
MXPA04001773A (es) Derivados de 6,7-dihidroxitetrahidroisquinolinas 3-sustituidas parta uso como agentes antibacterianos.
DE60201074D1 (en) Pyrazolopyridinderivate
MXPA03010259A (es) Nuevos derivados de 5-tio-ss-d-xilopiranosida, procedimiento de preparacion, composiciones farmaceuticas que los contienen y el uso terapeutico de los mismos.
EP1057829A4 (en) Condensed pyrimidine derivatives and pharmaceutical compositions containing them
IL166313A0 (en) Indoline derivatives and pharmaceutical compositions containing the same
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
MY123217A (en) Glycopeptide derivatives and pharmaceutical compositions containing the same